Peter Mueller - 11 Jun 2021 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Reporting relationship: Director
Issuer ticker: BTAI
Reported as of: 11 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2021, 17:33:18 UTC
Next SEC filing: 23 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Richard I. Steinhart, Attorney-in-Fact for Peter Mueller

Key filing fact

Peter Mueller filed Form 4 for BioXcel Therapeutics, Inc. (BTAI) on 15 Jun 2021.

Key facts

This page summarizes Peter Mueller's Form 4 filing for BioXcel Therapeutics, Inc. (BTAI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2021, 17:33.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BTAI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +14,500
Change %
Price: $0.000000
Shares after: 14,500
Date: 11 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,500
Exercise price: $37.86
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney